- Location
2
results for "
IMID
"-
Genmab Has Obtained FDA Fast Track Designation in Double Refractory Multiple Myeloma
Apr 4, 2013Biotechnology company Genmab has obtained FDA fast track designation in double refractory multiple myeloma for daratumumab. As per the designation, the human CD38 monoclonal antibody Daratumumab is suitable for multiple myeloma patients ...
-
Merck Will Be Presenting Its Innovative Portfolio of Display Materials in October
Oct 11, 2012•licristal®PS-VA for pioneering display technologies:Vivid images at minimal power consumption •licrivue®reactive mesogens:Enabling convenient 3D TV and enhancing display performance •WR Patinal®hydro-and ...
